LIDOCAINE HCL TOPICAL SOLUTION 40 MG
LIDOCAINE HYDROCHLORIDE : 40 MG · DIN 02489554 · HIKMA CANADA LIMITED
Health Canada status: APPROVED
What is LIDOCAINE HCL TOPICAL SOLUTION?
LIDOCAINE HCL TOPICAL SOLUTION 40 MG contains LIDOCAINE HYDROCHLORIDE : 40 MG. It is listed in the Health Canada Drug Product Database under DIN 02489554, held by HIKMA CANADA LIMITED, supplied as SOLUTION for TOPICAL administration. Health Canada currently lists it as approved, status dated 14-Jun-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02489554 |
|---|---|
| Brand name | LIDOCAINE HCL TOPICAL SOLUTION |
| Generic / active ingredient | LIDOCAINE HYDROCHLORIDE : 40 MG |
| Manufacturer | HIKMA CANADA LIMITED |
| Strength | 40 MG |
| Dosage form | SOLUTION |
| Route of administration | TOPICAL |
| Schedule | Ethical |
| ATC code | D04AB01 LIDOCAINE |
| AHFS class | 36:00.00 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 14-Jun-2022 |
| Original market date | 2020-06-15 00:00:00 |
Is LIDOCAINE in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Anticipated — reported by HIKMA CANADA LIMITED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code D04AB01 LIDOCAINE. 18 of 120 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AFTER SUN GEL | 0.8 % | GEL | FRUIT OF THE EARTH, INC | MARKETED | DIN 02499118 |
| ALOCANE PLUS | 4 % | GEL | QUEST PRODUCTS, LLC | MARKETED | DIN 02552590 |
| BACTINE FIRST AID SPRAY | 2.5 % | SPRAY | WELLSPRING PHARMACEUTICAL CANADA CORP | MARKETED | DIN 02150379 |
| DR. NUMB | 5 % | CREAM | SHINPHARMA INC | MARKETED | DIN 02354527 |
| LIDOCAINE | 4 % | GEL | THE MENTHOLATUM COMPANY OF CANADA LTD | MARKETED | DIN 02485311 |
| LIDODAN 4% TOPICAL SOLUTION | 4 % | SOLUTION | ODAN LABORATORIES LTD | MARKETED | DIN 02419505 |
| LIDODAN JELLY 2% | 20 MG | JELLY | ODAN LABORATORIES LTD | MARKETED | DIN 02143879 |
| LIDODAN OINTMENT 5% | 5 % | OINTMENT | ODAN LABORATORIES LTD | MARKETED | DIN 02083795 |
| MAXILENE 4 | 4 % | CREAM | RGR PHARMA LTD. | MARKETED | DIN 02244533 |
| MAXILENE 5 | 5 % | CREAM | RGR PHARMA LTD. | MARKETED | DIN 02245939 |
Who else supplies LIDOCAINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. LIDOCAINE appears in 8211 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.